Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.7 USD | +0.25% | +0.09% | +40.42% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 69.59M |
---|---|---|---|---|---|
Net income 2024 * | -5M | Net income 2025 * | -52M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.75
x | P/E ratio 2025 * |
-1.08
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.16% |
1 day | +0.25% | ||
1 week | +0.09% | ||
Current month | +0.09% | ||
1 month | -4.97% | ||
3 months | -10.61% | ||
6 months | +60.42% | ||
Current year | +40.42% |
Managers | Title | Age | Since |
---|---|---|---|
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
Sandeep Laumas
DFI | Director of Finance/CFO | 56 | 20-05-31 |
Mark Dudley
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Gibson
BRD | Director/Board Member | 67 | 20-05-31 |
Richard McGaughy
BRD | Director/Board Member | 52 | 20-05-31 |
Director/Board Member | 49 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 10.7 | +0.25% | 4,154 |
24-06-06 | 10.67 | +0.12% | 1,485 |
24-06-05 | 10.66 | 0.00% | 2,833 |
24-06-04 | 10.66 | -3.09% | 6,877 |
24-06-03 | 11 | +2.90% | 3,620 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.42% | 69.59M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TIL Stock